3 suspended. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Suspended 3 |
Follow Lymphoproliferative Disorders: new trials by email Literature Review of Lymphoproliferative Disorders trials Research Report on Lymphoproliferative Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma Single ASCT with Thalidomide maintenance - Multiple Myeloma | Phase 3 | Suspended | Shanghai Jiao Tong University School of Medicine | 80 | 2009-05-01 | 2016-05-10 |
| Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) Liposomal cytarabine, Intrathecal triple - Acute Lymphoblastic Leukemia | Phase 3 | Suspended | Nordic Society for Pediatric Hematology and Oncology | 100 | 2009-01-01 | 2012-10-10 |
| GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma autologous immunoglobulin idiotype-KLH conjugate vaccine, cyclophosphamide, doxorubicin hydrochloride - Lymphoma | Phase 3 | Suspended | Favrille | 480 | 2013-12-18 |
Leukemia (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Multiple Myeloma (1) · Neurotoxicity Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Lymphatic Diseases (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Leukemia, Lymphoid (1) · Lymphoma, B-Cell (1)
Antibodies, Monoclonal (1) · Biological Therapy (1) · Coal Tar (1) · Cyclophosphamide (1) · Cytarabine (1) · Doxorubicin (1) · Drug Therapy (1) · Immunization, Passive (1) · Immunotherapy, Active (1) · Melphalan (1) · Methods (1) · Methylprednisolone (1) · Prednisolone (1) · Prednisone (1) · Rituximab (1)
Favrille (1) · Nordic Society for Pediatric Hematology and Oncology (1) · Shanghai Jiao Tong University School of Medicine (1)
China (1) · Denmark (1) · Finland (1) · Iceland (1) · Norway (1) · Sweden (1) · United States (1)
Arja Harila-Saari, MD (1) · Jiong HU, M.D. (1) · John F. Bender, PharmD (1)